Abcellera Biologics Inc (ABCL)

$11.04 +0.15 (1.38%)
Market Cap 3.34B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 3,445,248
Avg Vol 7,196,424
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 38%
Beta 1.32
Analysts Strong Sell
Price Target $17.12

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon Sep. 14 at 7:04 PM
$ABCL You will REGRET not getting in at these prices TODAY when you see us tomorrow Over $13. 🚨We got GREAT NEWS and the BEST CONFERENCE CALL from Any CEO! CARL(CEO) HIT a HOMERUN!!! W/Bases FULL!! The only thing HOLDING $ABCL being at $13-15’ss today is Market CONDITIONS‼️ TOMORROW things will improve! More people today will digest this information and buy more after hours and Pre-Market! After that good luck we are off to RACES!! $14’sss-15’ssss I expect a surprise deal/partnership Announcement 📣 afterhours today or premarket! Expect $ABCL to RUN UP ALL WEEK‼️ the Charts 📈 indicating we close near $12’sss today and Open tomorrow near $13’sss!! Remember the LONGER the BASE…the BIGGER the BREAK-OUT!! DON’T CATCH Yourself MISSING OUT!! Market Conditions are just Temporary…I see them as a BUYING OPPORTUNITY!! With this type of NEWS and CONFERENCE CALL from our CEO CARL!!! HOLD on to your CHAIR 🪑 We ABOUT to SQUEEZE!!! The setup is nearly PERFECT!!! ENJOY the RIDE‼️🚨
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 6:34 PM
$ABCL DON’T Miss OUT!!! This company has EVERYTHING GOING for it‼️ Get in NOW!! We going to go do much HIGHER this WEEK!! Beautiful Chart 📈 GREAT NEWS 🗞️ Listen to the Call 📞 We are going to close Near $12 Today!!
0 · Reply
dick3
dick3 Sep. 14 at 6:28 PM
$ABCL has anyone mentioned when Hansen said we will not disclose targets. That's brilliant.
2 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 6:15 PM
$ABCL Look’s 👀 like we get More Great News After Hours or tomorrow Pre-Market!! If you haven’t Listen to the Carl Cantor Conference Call! It’s a MUST‼️ 🚨That is the best 30 minute Carl from any CEO I have EVER Listened too! Get in NOW lunch is almost over we heading to $12’sss! People are WAKING to $ABCL 11’sss is a gift! 🎁
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:56 PM
$ABCL $ABCL 🔥 🚀 $10–11 consolidation → reclaim $11.31 → break $12.2 → $13.24 → $15–16 → potentially $18.29.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:37 PM
$ABCL Look 👀 at LEVEL II!! We are starting to move to 12’sss!‼️
1 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:30 PM
$ABCL 🚨FOR SURE‼️ 💯 🚨Something happened late Friday afternoon and then Today for sure! The price surge was unnatural! I think they closed another TCE deal! Possible parters include: Oncology * Merck * BMS * Lilly * AstraZeneca * Regeneron Autoimmune / immune reset * Sanofi * Gilead * Lilly * Merck * possibly Novartis
1 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:24 PM
$ABCL LAST CHANCE to get in $11.19-$11.25‼️ After Lunch we TAKE OUT $12’ssss!!!
0 · Reply
Ripvip
Ripvip Sep. 14 at 5:14 PM
$ABCL news coming !
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:04 PM
$ABCL This is your CHANCE to GET IN! $11.19-11.25 after lunch we are going to take out $12’sss today‼️ Look 👀 at ALL the GREAT NEWS and Listen to CARL CEO CALL!! The best 30 MINUTE Call I have EVER LISTENED too🚨‼️ People are waking UP on $ABCL and know it’s so cheap in the $11’sss! It’s a GIFT!! 🎁
0 · Reply
Latest News on ABCL
AbCellera Biologics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference

Sep 9, 2026, 2:10 PM EDT - 5 days ago

AbCellera Biologics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

Sep 2, 2026, 4:05 PM EDT - 11 days ago

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026

AbCellera rises 17.0%

2026-08-25T16:06:05.000Z - 20 days ago

AbCellera rises 17.0%

AbCellera rises 10.7%

2026-08-25T14:06:36.000Z - 20 days ago

AbCellera rises 10.7%

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

Aug 13, 2026, 12:05 AM EDT - 4 weeks ago

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 4 weeks ago

AbCellera announces $200M common stock, warrants offering

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 11, 2026, 4:01 PM EDT - 4 weeks ago

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 4 weeks ago

AbCellera price target raised to $30 from $12 at Truist

AbCellera price target raised to $25 from $13 at JonesResearch

2026-08-10T19:55:32.000Z - 4 weeks ago

AbCellera price target raised to $25 from $13 at JonesResearch

AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 5 weeks ago

AbCellera Biologics Slides: Corporate presentation

AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 5 weeks ago

AbCellera Biologics Transcript: Study result

AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 5 weeks ago

AbCellera Biologics Press release: Study result

AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 5 weeks ago

AbCellera Biologics Slides: Study result

This Biotech's Drug Could Treat Hot Flashes. The Stock Is Up 32% on Good News.

Aug 10, 2026, 7:23 AM EDT - 5 weeks ago

This Biotech's Drug Could Treat Hot Flashes. The Stock Is Up 32% on Good News.

AbCellera menopause drug cuts hot flashes in mid-stage trial, shares rise

Aug 10, 2026, 7:13 AM EDT - 5 weeks ago

AbCellera menopause drug cuts hot flashes in mid-stage trial, shares rise

AbCellera announces Phase 1/2 trial of ABCL635 met primary efficacy endpoints

2026-08-10T11:11:27.000Z - 5 weeks ago

AbCellera announces Phase 1/2 trial of ABCL635 met primary efficacy endpoints

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

Aug 10, 2026, 7:00 AM EDT - 5 weeks ago

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile

AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026

Aug 7, 2026, 4:30 PM EDT - 5 weeks ago

AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026

AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 5 weeks ago

AbCellera price target raised to $9 from $8 at Stifel

AbCellera price target raised to $12 from $11 at Cantor Fitzgerald

2026-08-06T12:12:02.000Z - 5 weeks ago

AbCellera price target raised to $12 from $11 at Cantor Fitzgerald

AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 5 weeks ago

AbCellera Biologics Earnings Call Transcript: Q2 2026

AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 5 weeks ago

AbCellera Biologics Slides: Q2 2026

AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 5 weeks ago

AbCellera Biologics Earnings release: Q2 2026

AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 5 weeks ago

AbCellera Biologics Quarterly report: Q2 2026

AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 5 weeks ago

AbCellera Reports Q2 2026 Business Results

AbCellera announces collaboration with Vertex Pharmaceuticals

2026-07-29T11:27:06.000Z - 6 weeks ago

AbCellera announces collaboration with Vertex Pharmaceuticals

VRTX

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions

Jul 29, 2026, 7:00 AM EDT - 6 weeks ago

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions

3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts

2026-07-09T21:29:02.000Z - 2 months ago

3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts

NUVB SERV UBER

AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026

Jul 7, 2026, 4:05 PM EDT - 2 months ago

AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026

AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 2 months ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ

AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 2 months ago

AbCellera apponts Lynn Seely to board of directors

LYEL

AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jazz Pharma, AbCellera ink antibody deal worth up to $876 million

Jun 17, 2026, 7:43 AM EDT - 2 months ago

Jazz Pharma, AbCellera ink antibody deal worth up to $876 million

JAZZ

Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies

Jun 17, 2026, 7:00 AM EDT - 2 months ago

Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies

AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 3 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors

AbCellera Biologics Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 11:40 AM EDT - 3 months ago

AbCellera Biologics Transcript: Jefferies Global Healthcare Conference 2026

AbCellera Biologics Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 8:00 PM EDT - 4 months ago

AbCellera Biologics Transcript: Bank of America Global Healthcare Conference 2026

AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026

AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Earnings release: Q1 2026

AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Quarterly report: Q1 2026

AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 4 months ago

AbCellera Biologics Slides: Q1 2026

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

May 11, 2026, 4:05 PM EDT - 4 months ago

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

May 7, 2026, 4:05 PM EDT - 4 months ago

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Slides: Corporate presentation

AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing

AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing

AbCellera Biologics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference

Apr 21, 2026, 1:30 PM EDT - 4 months ago

AbCellera Biologics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Apr 20, 2026, 9:00 AM EDT - 4 months ago

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

Apr 1, 2026, 4:05 PM EDT - 5 months ago

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

AbCellera Biologics Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Mar 17, 2026, 4:30 PM EDT - 6 months ago

AbCellera Biologics Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

AbCellera Biologics Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 9:50 AM EST - 6 months ago

AbCellera Biologics Transcript: TD Cowen 46th Annual Health Care Conference

AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025

AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025

AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025

AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025

AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

Feb 11, 2026, 4:05 PM EST - 7 months ago

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

Jan 22, 2026, 4:05 PM EST - 7 months ago

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

AbCellera Biologics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 8 months ago

AbCellera Biologics Transcript: 44th Annual J.P. Morgan Healthcare Conference

AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 8 months ago

AbCellera Biologics Slides: Corporate presentation

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

Jan 12, 2026, 9:00 AM EST - 8 months ago

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

AbCellera and Bruker Reach Global Settlement of Patent Litigation

Dec 18, 2025, 9:00 AM EST - 9 months ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 8, 2025, 4:05 PM EST - 9 months ago

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

AbCellera Biologics Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 8:00 AM EST - 9 months ago

AbCellera Biologics Transcript: Piper Sandler 37th Annual Healthcare Conference

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 10 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025

AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025

AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025

AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025

AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Oct 7, 2025, 4:05 PM EDT - 11 months ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 29, 2025, 4:05 PM EDT - 11 months ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 1 year ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

AbCellera Biologics Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 5, 2025, 9:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 27, 2025, 9:00 AM EDT - 1 year ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 12, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in September

AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025

AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025

AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025

AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Aug 7, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 7, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

AbCellera Biologics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 9, 2025, 10:40 AM EDT - 1 year ago

AbCellera Biologics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 30, 2025, 1:00 PM EDT - 1 year ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 14, 2025, 5:00 PM EDT - 1 year ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 12, 2025, 3:30 PM EDT - 1 year ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 9, 2025, 7:30 PM EDT - 1 year ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025

AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025

AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025

AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025

AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results

AbCellera Biologics Transcript: Bloom Burton & Co. Healthcare Investor Conference 2025

May 5, 2025, 9:30 AM EDT - 1 year ago

AbCellera Biologics Transcript: Bloom Burton & Co. Healthcare Investor Conference 2025

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 29, 2025, 3:00 PM EDT - 1 year ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing

AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 3, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Mar 25, 2025, 4:30 PM EDT - 1 year ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

AbCellera Biologics Transcript: KeyBanc Annual Health Care Forum

Mar 19, 2025, 1:30 PM EDT - 1 year ago

AbCellera Biologics Transcript: KeyBanc Annual Health Care Forum

AbCellera Biologics Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: TD Cowen 45th Annual Healthcare Conference

AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024

AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024

AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024

AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024

AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results

AbCellera to Participate at Upcoming Investor Conferences in March

Feb 11, 2025, 4:05 PM EST - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in March

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 21, 2025, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

AbCellera Biologics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Jan 13, 2025, 9:00 AM EST - 1 year ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

AbCellera Biologics Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 3, 2024, 2:30 PM EST - 1 year ago

AbCellera Biologics Transcript: Piper Sandler 36th Annual Healthcare Conference

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 21, 2024, 4:05 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

AbCellera Biologics Transcript: Jefferies London Healthcare Conference 2024

Nov 19, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Jefferies London Healthcare Conference 2024

AbCellera Biologics Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 11:30 AM EST - 1 year ago

AbCellera Biologics Transcript: Stifel 2024 Healthcare Conference

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024

AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024

AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024

AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024

AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

Stocktradesmoon
Stocktradesmoon Sep. 14 at 7:04 PM
$ABCL You will REGRET not getting in at these prices TODAY when you see us tomorrow Over $13. 🚨We got GREAT NEWS and the BEST CONFERENCE CALL from Any CEO! CARL(CEO) HIT a HOMERUN!!! W/Bases FULL!! The only thing HOLDING $ABCL being at $13-15’ss today is Market CONDITIONS‼️ TOMORROW things will improve! More people today will digest this information and buy more after hours and Pre-Market! After that good luck we are off to RACES!! $14’sss-15’ssss I expect a surprise deal/partnership Announcement 📣 afterhours today or premarket! Expect $ABCL to RUN UP ALL WEEK‼️ the Charts 📈 indicating we close near $12’sss today and Open tomorrow near $13’sss!! Remember the LONGER the BASE…the BIGGER the BREAK-OUT!! DON’T CATCH Yourself MISSING OUT!! Market Conditions are just Temporary…I see them as a BUYING OPPORTUNITY!! With this type of NEWS and CONFERENCE CALL from our CEO CARL!!! HOLD on to your CHAIR 🪑 We ABOUT to SQUEEZE!!! The setup is nearly PERFECT!!! ENJOY the RIDE‼️🚨
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 6:34 PM
$ABCL DON’T Miss OUT!!! This company has EVERYTHING GOING for it‼️ Get in NOW!! We going to go do much HIGHER this WEEK!! Beautiful Chart 📈 GREAT NEWS 🗞️ Listen to the Call 📞 We are going to close Near $12 Today!!
0 · Reply
dick3
dick3 Sep. 14 at 6:28 PM
$ABCL has anyone mentioned when Hansen said we will not disclose targets. That's brilliant.
2 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 6:15 PM
$ABCL Look’s 👀 like we get More Great News After Hours or tomorrow Pre-Market!! If you haven’t Listen to the Carl Cantor Conference Call! It’s a MUST‼️ 🚨That is the best 30 minute Carl from any CEO I have EVER Listened too! Get in NOW lunch is almost over we heading to $12’sss! People are WAKING to $ABCL 11’sss is a gift! 🎁
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:56 PM
$ABCL $ABCL 🔥 🚀 $10–11 consolidation → reclaim $11.31 → break $12.2 → $13.24 → $15–16 → potentially $18.29.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:37 PM
$ABCL Look 👀 at LEVEL II!! We are starting to move to 12’sss!‼️
1 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:30 PM
$ABCL 🚨FOR SURE‼️ 💯 🚨Something happened late Friday afternoon and then Today for sure! The price surge was unnatural! I think they closed another TCE deal! Possible parters include: Oncology * Merck * BMS * Lilly * AstraZeneca * Regeneron Autoimmune / immune reset * Sanofi * Gilead * Lilly * Merck * possibly Novartis
1 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:24 PM
$ABCL LAST CHANCE to get in $11.19-$11.25‼️ After Lunch we TAKE OUT $12’ssss!!!
0 · Reply
Ripvip
Ripvip Sep. 14 at 5:14 PM
$ABCL news coming !
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 5:04 PM
$ABCL This is your CHANCE to GET IN! $11.19-11.25 after lunch we are going to take out $12’sss today‼️ Look 👀 at ALL the GREAT NEWS and Listen to CARL CEO CALL!! The best 30 MINUTE Call I have EVER LISTENED too🚨‼️ People are waking UP on $ABCL and know it’s so cheap in the $11’sss! It’s a GIFT!! 🎁
0 · Reply
JiZzM0pper216
JiZzM0pper216 Sep. 14 at 5:00 PM
$ABCL this is the longest consolidation since under 3 for years!!@ bullish with yall
1 · Reply
JiZzM0pper216
JiZzM0pper216 Sep. 14 at 4:48 PM
$ABCL insiders own bulk of the float they should retire those shares.float aint really 320+ its 100+ haha
0 · Reply
JiZzM0pper216
JiZzM0pper216 Sep. 14 at 4:40 PM
$ABCL nice chart mad strength on sad volume. Insanely bullish.
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 4:34 PM
$ABCL You DON’T want to be Chasing in the $13-15’ss. $11.30’ss is a very great entry‼️🚨 We’re going to be MOVING UP all week long!! BEAUTIFUL CHART 📈!!! GREAT CONSOLIDATION! HUGE BUY’S!! CARL GREAT NEWS 🗞️ is making itself AROUND‼️ 🤯 WHEN this amount of Volume is coming in a deal or partnership has been leaked! EXPECT MORE GREAT NEWS AFTER HOURS🚨 REMEMBER I told you ALL…the Longer the BASE…the BIGGER the BREAK OUT!! Here comes $14’ss-$15’sss!!
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 4:16 PM
$ABCL OVER $1,000,000 MILLION BOUGHT in the last 30min!!! Get in NOW!! This rocket 🚀 is about to TAKE OFF!!! Look 👀 at LEVEL II!! 🚨 Carl GREAT NEWS 📰 is making its WAY AROUND!! *** The MM’s and SHORTS CAN’T KEEP these prices LOW ANY-LONGER!!! $13-15 this week!! Carl from his OWN MOUTH “PATIENT’S WERE CURED” do you have any idea how BIG of DEAL that is!!! Especially coming from a CEO!!! That is UNHEARD OF‼️ “Patients went from having 10 EVENTS a day to “ZERO” 😮 😮 🤯
2 · Reply
Stockingtrade
Stockingtrade Sep. 14 at 4:07 PM
$ABCL Market is down, but $ABCL spiked on Friday, and again this morning.... Is there a deal coming this week or something??
1 · Reply
snowPOW
snowPOW Sep. 14 at 4:03 PM
$ABCL up on low volume!? Wonder what happens when volume rolls back in!?
0 · Reply
Rastafari
Rastafari Sep. 14 at 3:37 PM
$ABCL why block stocktradesmoon? He helps the board with energy and good summaries!
3 · Reply
Coolbhart
Coolbhart Sep. 14 at 3:31 PM
$ABCL does everyone just block stocktradesmoon? that’s ridiculous
2 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 3:29 PM
$ABCL We’re going Much HIGHER$13-15!! Look 👀 at ALL the GREAT NEWS 📰 and Carl Cantor NEWs Conference Call! Listen to it!! 👂 🎧
0 · Reply
villaspecialisten
villaspecialisten Sep. 14 at 3:23 PM
$ABCL i hope we're up to a rally. Bought in at pre market 10.71 650 shares but will add more if it shows momentum
0 · Reply
Stocktradesmoon
Stocktradesmoon Sep. 14 at 2:56 PM
$ABCL ADDED 10K MORE‼️ $ABCL OVER $2,500,000 Million JUST BOUGHT in the last 1 hour Friday. 🤯 People are WAKING UP‼️ 🚨‼️READ my POST’s!! You Will UNDERSTAND WHY!! GET IN NOW!!! ABCL too VALUABLE NO MORE $10’s! Investors are digesting all the Nuggets Carl spoke about on the conference! It’s a MUST LISTEN! 🎧 🎧 👂 Best 30 minute Conference call I have EVER LISTENED TOO!!! ‼️Don’t be FOOLED! Market Conditions has ABCL trading at a huge discount this week! Wait until many people listen 👂 to the call today and this weekend we will be OPENING in the Mid 11’ssss on MONDAY!!! AS people spend Today listening to CALL and the WEEKEND digesting this information. 🚨 🚨🚨CEO CARL Quoted Phase II RESULTS were so IMPRESSIVE that “Patients were “CURED” after 4 weeks. From ten events a day to “ZERO” 🤯 🤯 GET in NOW!!!! $13-$15’sss next week for SURE‼️ 💯 $ABCL 🔥 🚀 $10–11 consolidation → reclaim $11.31 → break $12.2 → $13.24 → $15–16 → potentially $18.29.
0 · Reply